Clinical Trials Logo

Clinical Trial Summary

The number of patients with lower extremity varicose veins has been increasing due to an aging population, with treatments divided into conservative and invasive methods. Current treatments can be expensive and inaccessible for some patients. Entelon, a relatively inexpensive intravenous drug, has shown promise in improving symptoms related to venous lymphatic dysfunction, but its objective vascular function improvement hasn't been proven. This study aims to assess the effectiveness of Vitis Vinifera seed extract (Entelon®) combined with lifestyle therapy in patients with varicose veins, using follow-up Doppler ultrasonography to measure venous reflux improvement.


Clinical Trial Description

Varicose veins in the lower extremities are more than the function of the valve membranes on the inside of the legs, and the heart cannot function, resulting in regurgitation in the lower half of the body. This causes blood to pool in the lower extremities and causes various symptoms. Large stalks of superficial veins and venous valves of deep veins become dysfunctional, resulting in an increase in blood vessels in the calf area with backflow of blood. The valvular insufficiency of lower extremity veins is the main cause. In general, it occurs in the great saphenous vein that flows into the deep vein from the groin, the small saphenous vein in the posterior leg, and the perforating vein in the calf. Reflux in superficial veins (e.g. great saphenous vein, small saphenous vein) and deep veins can generally be confirmed using Doppler ultrasound. Determine the direction of treatment by confirming if there is branch vein dilatation. Ultrasonography is also done on the opposite, unaffected side, even if symptoms are in only one leg. Treatment of varicose veins can generally be divided into conservative treatment and invasive treatment, and lifestyle correction and wearing compression stockings are recommended as conservative treatment. Surgical treatment is indicated when conservative treatment is ineffective or interferes with daily life. Symptoms can be alleviated by removing superficial veins with regurgitation due to valvular insufficiency, or by inducing hardening of the causative blood vessels using high frequency or laser to block regurgitation and prevent blood flow. However, most of these treatments are non-salary items, and are relatively expensive treatment methods that impose a large financial burden on patients. In addition, deep veins are responsible for 90% of blood transport, but surgical treatment is impossible and only conservative treatment is possible. As a non-invasive treatment, which is an intravenous active agent, is registered as a drug to be administered, and improvement of symptoms related to venous lymphatic dysfunction (pain, lower extremity anxiety symptoms) is attracting attention. It is relatively inexpensive compared to surgical treatment, but until now, objective improvement of vascular function by drug treatment has not been proven. Vitis Vinifera seed extract (Entelon®) was launched in 1998 and its safety has already been confirmed, and the investigators have investigated the effect of lower limit volume reduction compared to placebo after administration of Vitis Vinifera seed extract in patients with edema. (Sano A, Tokutake S, Seo A. Proanthocyanidin-rich grape seed extract reduces leg swelling in healthy women during prolonged sitting. J Sci Food Agric. 2013 Feb;93(3):457-62.). In this study, along with lifestyle therapy in patients with varicose veins, follow-up Doppler ultrasonography after administration of Entelon will be used to confirm the improvement effect of venous reflux. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05851183
Study type Interventional
Source Yonsei University
Contact SungA Bae, MD, PhD
Phone 82-10-2327-3578
Email cardiobsa@yuhs.ac
Status Recruiting
Phase Phase 4
Start date July 20, 2023
Completion date April 25, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05930587 - Effect of Cold Immersion on Patients With Varicose Vein N/A
Recruiting NCT04546750 - Prospective Cohort Study for Varicose Veins Incidence and Natural Course
Completed NCT05372146 - Great Saphenous Vein Sparing Segmental Radiofrequency Ablation in Varicose Veins Patients N/A
Recruiting NCT06124664 - Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities
Completed NCT03613376 - Compression And Functional Ability After Endovenous Varicose Vein Treatment N/A
Completed NCT04148950 - Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Disease N/A
Completed NCT04658901 - ACOART RF CLOSURE:Radiofrequency for Varicose Veins of Lower Extremity in China N/A
Not yet recruiting NCT04794712 - Evaluation of Pain Associated With Chronic Venous Insufficiency
Recruiting NCT05581524 - Vacuum Assisted Sclerotherapy Performed by Catheter N/A
Completed NCT04720027 - Long Term Study of 3 Radiofrequency Devices
Completed NCT05058989 - The Evaluation of the Pathophysiology of Varicose Veins in Pregnancy
Recruiting NCT03035747 - Ongoing Registry of Treatment of Chronic Venous Diseases
Completed NCT05468450 - RCT Comparing EVLA Versus Polidocanol Foam in the Treatment of SSV Insufficiency N/A
Completed NCT03722134 - Mechanochemical Ablation vs Thermal Ablation N/A
Active, not recruiting NCT04726124 - MicrOwave and laSer ablaTion Study (MOST Study) N/A
Active, not recruiting NCT06387264 - Compont - Varicose Veins of the Lower Extremities N/A
Recruiting NCT03293836 - Venous Ulcer: Endovenous Radiofrequency Treatment Trial N/A
Recruiting NCT04645771 - Safety and Efficacy Study of Endovenous Microwave Ablation for Treatment of Varicose Veins N/A
Enrolling by invitation NCT06175546 - Daily Duration of Compression Treatment in Patients With Symptomatic Chronic Venous Disease N/A
Not yet recruiting NCT05654233 - The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy N/A